Vertex Pharmaceuticals, Inc’s filing revealed that its EVP, Chief Scientific Officer ALTSHULER DAVID unloaded Company’s shares for reported $1.65 million on Mar 13 ’25. In the deal valued at $510.00 per share,3,231 shares were sold. As a result of this transaction, ALTSHULER DAVID now holds 23,281 shares worth roughly $11.96 million.
Then, ALTSHULER DAVID bought 3,231 shares, generating $1,647,810 in total proceeds.
Before that, WAGNER CHARLES F JR sold 3,298 shares. Vertex Pharmaceuticals, Inc shares valued at $1,649,000 were divested by the EVP & Chief Financial Officer at a price of $500.00 per share. As a result of the transaction, WAGNER CHARLES F JR now holds 51,671 shares, worth roughly $26.55 million.
Canaccord Genuity upgraded its Vertex Pharmaceuticals, Inc [VRTX] rating to a Hold from a a Sell in a research note published on February 12, 2025; the price target was increased to $424 from $408. A number of analysts have revised their coverage, including Canaccord Genuity’s analysts, who increased its forecast for the stock in mid February from “a Sell” to “a Hold”. Wells Fargo also remained covering VRTX and has decreased its forecast on January 30, 2025 with a “an Equal weight” recommendation from previously “an Overweight” rating. H.C. Wainwright maintained its rating on December 20, 2024. It rated VRTX as “a Buy”.
Price Performance Review of VRTX
On Monday, Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] saw its stock jump 1.78% to $513.76. Over the last five days, the stock has gained 2.75%. Vertex Pharmaceuticals, Inc shares have risen nearly 27.58% since the year began. Nevertheless, the stocks have risen 24.34% over the past one year. While a 52-week high of $519.88 was reached on 03/14/25, a 52-week low of $377.85 was recorded on 01/13/25. SMA at 50 days reached $458.42, while 200 days put it at $468.56.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 506.11, which if violated will result in even more drops to 498.45. On the upside, there is a resistance level at 519.31. A further resistance level may holdings at 524.85. The Relative Strength Index (RSI) on the 14-day chart is 69.94, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 16.16, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 12.82%. Stochastics %K at 76.61% indicates the stock is a holding.
How much short interest is there in Vertex Pharmaceuticals, Inc?
A steep rise in short interest was recorded in Vertex Pharmaceuticals, Inc stocks on 2025-02-28, growing by 0.92 million shares to a total of 5.48 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 4.56 million shares. There was a rise of 16.82%, which implies that there is a positive sentiment for the stock.
